Cargando…

Comparative effectiveness of home dialysis therapies: a matched cohort study

BACKGROUND: Home dialysis is being increasingly promoted among patients with end-stage renal disease, but the comparative effectiveness of home hemodialysis and peritoneal dialysis is unknown. OBJECTIVE: To determine whether patients receiving home daily hemodialysis have reduced mortality risk comp...

Descripción completa

Detalles Bibliográficos
Autores principales: Nesrallah, Gihad E., Li, Lihua, Suri, Rita S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4802626/
https://www.ncbi.nlm.nih.gov/pubmed/27006781
http://dx.doi.org/10.1186/s40697-016-0105-x
_version_ 1782422759189512192
author Nesrallah, Gihad E.
Li, Lihua
Suri, Rita S.
author_facet Nesrallah, Gihad E.
Li, Lihua
Suri, Rita S.
author_sort Nesrallah, Gihad E.
collection PubMed
description BACKGROUND: Home dialysis is being increasingly promoted among patients with end-stage renal disease, but the comparative effectiveness of home hemodialysis and peritoneal dialysis is unknown. OBJECTIVE: To determine whether patients receiving home daily hemodialysis have reduced mortality risk compared with matched patients receiving home peritoneal dialysis. DESIGN: This study is an observational, propensity-matched, new-user cohort study. SETTING: Linked electronic data were from the United States Renal Data System (USRDS) and a large dialysis provider’s database. PATIENTS: The patients were adults receiving in-center hemodialysis in the USA between 2004 and 2011 and registered in the USRDS. MEASUREMENTS: Baseline comorbidities, demographics, and outcomes for both groups were ascertained from the United States Renal Data System. METHODS: We identified 3142 consecutive adult patients initiating home daily hemodialysis (≥5 days/week for ≥1.5 h/day) and matched 2688 of them by propensity score to 2688 contemporaneous US patients initiating home peritoneal dialysis. We used Cox regression to compare all-cause mortality between groups. RESULTS: After matching, the two groups were well balanced on all baseline characteristics. Mean age was 51 years, 66 % were male, 72 % were white, and 29 % had diabetes. During 10,221 patient-years of follow-up, 1493/5336 patients died. There were significantly fewer deaths among patients receiving home daily hemodialysis than those receiving peritoneal dialysis (12.7 vs 16.7 deaths per 100 patient-years, respectively; hazard ratio (HR) 0.75; 95 % CI 0.68–0.82; p < 0.001). Similar results were noted with several different analytic methods and for all pre-specified subgroups. LIMITATIONS: We cannot exclude residual confounding in this observational study. CONCLUSIONS: Home daily hemodialysis was associated with lower mortality risk than home peritoneal dialysis. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s40697-016-0105-x) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4802626
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-48026262016-03-23 Comparative effectiveness of home dialysis therapies: a matched cohort study Nesrallah, Gihad E. Li, Lihua Suri, Rita S. Can J Kidney Health Dis Original Research Article BACKGROUND: Home dialysis is being increasingly promoted among patients with end-stage renal disease, but the comparative effectiveness of home hemodialysis and peritoneal dialysis is unknown. OBJECTIVE: To determine whether patients receiving home daily hemodialysis have reduced mortality risk compared with matched patients receiving home peritoneal dialysis. DESIGN: This study is an observational, propensity-matched, new-user cohort study. SETTING: Linked electronic data were from the United States Renal Data System (USRDS) and a large dialysis provider’s database. PATIENTS: The patients were adults receiving in-center hemodialysis in the USA between 2004 and 2011 and registered in the USRDS. MEASUREMENTS: Baseline comorbidities, demographics, and outcomes for both groups were ascertained from the United States Renal Data System. METHODS: We identified 3142 consecutive adult patients initiating home daily hemodialysis (≥5 days/week for ≥1.5 h/day) and matched 2688 of them by propensity score to 2688 contemporaneous US patients initiating home peritoneal dialysis. We used Cox regression to compare all-cause mortality between groups. RESULTS: After matching, the two groups were well balanced on all baseline characteristics. Mean age was 51 years, 66 % were male, 72 % were white, and 29 % had diabetes. During 10,221 patient-years of follow-up, 1493/5336 patients died. There were significantly fewer deaths among patients receiving home daily hemodialysis than those receiving peritoneal dialysis (12.7 vs 16.7 deaths per 100 patient-years, respectively; hazard ratio (HR) 0.75; 95 % CI 0.68–0.82; p < 0.001). Similar results were noted with several different analytic methods and for all pre-specified subgroups. LIMITATIONS: We cannot exclude residual confounding in this observational study. CONCLUSIONS: Home daily hemodialysis was associated with lower mortality risk than home peritoneal dialysis. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s40697-016-0105-x) contains supplementary material, which is available to authorized users. BioMed Central 2016-03-20 /pmc/articles/PMC4802626/ /pubmed/27006781 http://dx.doi.org/10.1186/s40697-016-0105-x Text en © Nesrallah et al. 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Original Research Article
Nesrallah, Gihad E.
Li, Lihua
Suri, Rita S.
Comparative effectiveness of home dialysis therapies: a matched cohort study
title Comparative effectiveness of home dialysis therapies: a matched cohort study
title_full Comparative effectiveness of home dialysis therapies: a matched cohort study
title_fullStr Comparative effectiveness of home dialysis therapies: a matched cohort study
title_full_unstemmed Comparative effectiveness of home dialysis therapies: a matched cohort study
title_short Comparative effectiveness of home dialysis therapies: a matched cohort study
title_sort comparative effectiveness of home dialysis therapies: a matched cohort study
topic Original Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4802626/
https://www.ncbi.nlm.nih.gov/pubmed/27006781
http://dx.doi.org/10.1186/s40697-016-0105-x
work_keys_str_mv AT nesrallahgihade comparativeeffectivenessofhomedialysistherapiesamatchedcohortstudy
AT lilihua comparativeeffectivenessofhomedialysistherapiesamatchedcohortstudy
AT suriritas comparativeeffectivenessofhomedialysistherapiesamatchedcohortstudy